A detailed history of Cutter & CO Brokerage, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 7,306 shares of ABBV stock, worth $1.34 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
7,306
Previous 7,395 1.2%
Holding current value
$1.34 Million
Previous $1.27 Million 13.72%
% of portfolio
0.35%
Previous 0.33%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$163.84 - $199.33 $14,581 - $17,740
-89 Reduced 1.2%
7,306 $1.44 Million
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $13,931 - $16,268
90 Added 1.23%
7,395 $1.27 Million
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $56,256 - $64,099
-352 Reduced 4.6%
7,305 $1.33 Million
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $17,062 - $19,216
124 Added 1.65%
7,657 $1.19 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $16,965 - $19,640
-127 Reduced 1.66%
7,533 $1.12 Million
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $25,971 - $32,320
196 Added 2.63%
7,660 $1.03 Million
Q1 2023

May 09, 2023

SELL
$144.61 - $166.54 $67,388 - $77,607
-466 Reduced 5.88%
7,464 $1.19 Million
Q4 2022

Feb 03, 2023

SELL
$138.31 - $165.87 $106,498 - $127,719
-770 Reduced 8.85%
7,930 $1.28 Million
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $74,889 - $85,892
-558 Reduced 6.03%
8,700 $1.17 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $322,443 - $409,931
-2,343 Reduced 20.2%
9,258 $1.42 Million
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $252,477 - $313,253
1,913 Added 19.75%
11,601 $1.88 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $71,118 - $89,985
662 Added 7.33%
9,688 $1.31 Million
Q3 2021

Nov 02, 2021

SELL
$106.4 - $120.78 $28,196 - $32,006
-265 Reduced 2.85%
9,026 $974,000
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $86,482 - $96,346
822 Added 9.71%
9,291 $1.05 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $163,986 - $180,529
1,603 Added 23.35%
8,469 $916,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $3,300 - $4,455
41 Added 0.6%
6,866 $736,000
Q3 2020

Nov 05, 2020

BUY
$85.91 - $100.83 $203,005 - $238,261
2,363 Added 52.96%
6,825 $598,000
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $60,456 - $80,900
824 Added 22.65%
4,462 $438,000
Q1 2020

May 05, 2020

SELL
$64.5 - $97.79 $19,737 - $29,923
-306 Reduced 7.76%
3,638 $277,000
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $10,675 - $13,357
148 Added 3.9%
3,944 $349,000
Q3 2019

Nov 07, 2019

BUY
$62.98 - $75.72 $61,279 - $73,675
973 Added 34.47%
3,796 $287,000
Q2 2019

Jul 31, 2019

SELL
$65.7 - $83.98 $2,956 - $3,779
-45 Reduced 1.57%
2,823 $205,000
Q4 2018

Feb 07, 2019

BUY
$77.85 - $96.01 $4,048 - $4,992
52 Added 1.85%
2,868 $264,000
Q3 2018

Oct 12, 2018

BUY
$88.91 - $98.84 $15,648 - $17,395
176 Added 6.67%
2,816 $266,000
Q2 2018

Jul 30, 2018

BUY
$89.78 - $106.23 $89 - $106
1 Added 0.04%
2,640 $245,000
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $7,912 - $10,596
86 Added 3.37%
2,639 $250,000
Q4 2017

Jan 30, 2018

BUY
$89.56 - $98.21 $228,646 - $250,730
2,553
2,553 $247,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.